Novel Light-sensitive Compounds Show Promise For Cancer Therapy
Tuesday, June 16, 2009 - 12:29
in Health & Medicine
Chemists have developed novel compounds that show promise for photodynamic cancer therapy, which uses light-activated drugs to kill tumor cells. The new compounds, called dye-sensitized ruthenium nitrosyls, are absorbed by cancer cells and respond to specific wavelengths of light by releasing nitric oxide, which triggers cell death.
Read the whole article on Science Daily
More from Science Daily
Related
- Novel light-sensitive compounds show promise for cancer therapyTue, 16 Jun 2009, 11:38:45 EDT
- Sensitizing tumor response to cancer therapyWed, 5 Aug 2009, 15:23:32 EDT
- Two new compounds show promise for eliminating breast cancer tumorsWed, 19 Nov 2008, 7:08:59 EST
- First compound that specifically kills cancer stem cells foundThu, 13 Aug 2009, 12:39:50 EDT
- Study supports DNA repair-blocker research in cancer therapyMon, 17 Aug 2009, 11:22:47 EDT